Inflammation: the sparkplug for chronic diseases

The results of an important clinical study show that canakinumab, a new anti-inflammatory medication, diminishes the risks of heart attacks and of lung cancer, confirming the essential role of inflammation in the development of these diseases. Download the column

23-Oct-2017 |

Share this content!

Recent Articles

Column Archives

Column Keywords